Abstract
We present a simple epidemiological model that includes demographic density, social distancing, and efficacy of massive testing and quarantine as the main parameters to model the progression of COVID-19 pandemics in densely populated urban areas (i.e., above 5,000 inhabitants km2). Our model demonstrates that effective containment of pandemic progression in densely populated cities is achieved only by combining social distancing and widespread testing for quarantining of infected subjects. Our results suggest that extreme social distancing without intensive testing is ineffective in extinguishing COVID-19. This finding has profound epidemiological significance and sheds light on the controversy regarding the relative effectiveness of widespread testing and social distancing. Our simple epidemiological simulator is also useful for assessing the efficacy of governmental/societal responses to an outbreak.
This study also has relevant implications for the concept of smart cities, as densely populated areas are hotspots that are highly vulnerable to epidemic crises.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
MMA and GTdS acknowledge the funding received from CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico) and Tecnologico de Monterrey.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
NA
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All relevant data and programs to reproduce the information presented here is available at the manuscript or as supplementary material.
